T. Rowe Price Associates’s Amdocs DOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.61M | Sell |
55,355
-103,089
| -65% | -$7.54M | ﹤0.01% | 1566 |
|
|
2025
Q4 | $12.8M | Sell |
158,444
-18,491
| -10% | -$1.49M | ﹤0.01% | 1178 |
|
|
2025
Q3 | $14.5M | Buy |
176,935
+24,384
| +16% | +$2.11M | ﹤0.01% | 1138 |
|
|
2025
Q2 | $13.9M | Buy |
152,551
+2,212
| +1% | +$198K | ﹤0.01% | 1051 |
|
|
2025
Q1 | $13.8M | Buy |
150,339
+13,360
| +10% | +$1.17M | ﹤0.01% | 1042 |
|
|
2024
Q4 | $11.7M | Buy |
136,979
+10,797
| +9% | +$947K | ﹤0.01% | 1126 |
|
|
2024
Q3 | $11M | Buy |
126,182
+26,761
| +27% | +$2.25M | ﹤0.01% | 1123 |
|
|
2024
Q2 | $7.85M | Buy |
99,421
+51,383
| +107% | +$4.22M | ﹤0.01% | 1145 |
|
|
2024
Q1 | $4.34M | Buy |
48,038
+4,662
| +11% | +$425K | ﹤0.01% | 1256 |
|
|
2023
Q4 | $3.81M | Buy |
43,376
+3,096
| +8% | +$258K | ﹤0.01% | 1292 |
|
|
2023
Q3 | $3.4M | Buy |
40,280
+2,851
| +8% | +$258K | ﹤0.01% | 1283 |
|
|
2023
Q2 | $3.7M | Buy |
37,429
+1,134
| +3% | +$107K | ﹤0.01% | 1269 |
|
|
2023
Q1 | $3.49M | Buy |
36,295
+961
| +3% | +$88.9K | ﹤0.01% | 1270 |
|
|
2022
Q4 | $3.21M | Buy |
35,334
+1,489
| +4% | +$127K | ﹤0.01% | 1290 |
|
|
2022
Q3 | $2.69M | Buy |
33,845
+8,265
| +32% | +$700K | ﹤0.01% | 1343 |
|
|
2022
Q2 | $2.13M | Buy |
25,580
+18,402
| +256% | +$1.52M | ﹤0.01% | 1595 |
|
|
2022
Q1 | $590K | Buy |
7,178
+1,751
| +32% | +$137K | ﹤0.01% | 2265 |
|
|
2021
Q4 | $406K | Sell |
5,427
-2,129
| -28% | -$160K | ﹤0.01% | 2487 |
|
|
2021
Q3 | $572K | Sell |
7,556
-323
| -4% | -$25K | ﹤0.01% | 2312 |
|
|
2021
Q2 | $610K | Buy |
7,879
+1,367
| +21% | +$106K | ﹤0.01% | 2295 |
|
|
2021
Q1 | $457K | Buy |
6,512
+703
| +12% | +$53.1K | ﹤0.01% | 2413 |
|
|
2020
Q4 | $412K | Sell |
5,809
-52
| -0.9% | -$3.26K | ﹤0.01% | 2319 |
|
|
2020
Q3 | $336K | Sell |
5,861
-131
| -2% | -$7.83K | ﹤0.01% | 2248 |
|
|
2020
Q2 | $365K | Sell |
5,992
-376
| -6% | -$23.2K | ﹤0.01% | 2181 |
|
|
2020
Q1 | $350K | Sell |
6,368
-21
| -0.3% | -$1.41K | ﹤0.01% | 2140 |
|
|
2019
Q4 | $461K | Buy |
+6,389
| New | +$435K | ﹤0.01% | 2175 |
|
|
2019
Q1 | – | Sell |
-3,515
| Closed | -$206K | – | 2536 |
|
|
2018
Q4 | $206K | Buy |
3,515
+198
| +6% | +$12.4K | ﹤0.01% | 2405 |
|
|
2018
Q3 | $219K | Buy |
+3,317
| New | +$219K | ﹤0.01% | 2443 |
|
|
2013
Q4 | – | Sell |
-5,037,000
| Closed | -$185M | – | 2493 |
|
|
2013
Q3 | $185M | Sell |
5,037,000
-5,250,700
| -51% | -$198M | 0.05% | 424 |
|
|
2013
Q2 | $382M | Buy |
+10,287,700
| New | +$367M | 0.1% | 249 |
|
Other funds holding DOX
BGC
BIP
VPM
T. Rowe Price Associates's DOX Position: Q1 2026 in Review
T. Rowe Price Associates reduced its Amdocs (DOX) stake by 65% in Q1 2026, selling an estimated $7.54M and leaving 55,355 shares worth $3.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1566.
T. Rowe Price Associates first reported a position in DOX in Q2 2013 and has held it in 30 quarters since. The position peaked at $382M in Q2 2013. 473 funds tracked by Wall St. Rank hold DOX as of Q1 2026.
- T. Rowe Price Associates held 55,355 shares of Amdocs worth $3.61M as of Q1 2026.
- T. Rowe Price Associates sold 103,089 Amdocs shares in Q1 2026, an estimated $7.54M.
- Amdocs made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1566 holding.
- T. Rowe Price Associates first reported a position in Amdocs in Q2 2013 and has held it in 30 quarters since.
- T. Rowe Price Associates's Amdocs position peaked at $382M in Q2 2013.
- 473 funds tracked by Wall St. Rank held Amdocs as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.